TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29902542

Group type: EXPERIMENTAL
Intervention: Topical spray treatment with 0.005% rhEGF
Number of subjects: 167

Group type: COMPARATOR
Intervention: Saline spray (placebo)
Number of subjects: 167
Study: 27085389

Group type: EXPERIMENTAL
Intervention: Transcatheter aortic valve replacement (TAVR)
Number of subjects: 750

Group type: COMPARATOR
Intervention: Surgical aortic valve replacement (SAVR)
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: TAVR
Number of subjects: 750

Group type: COMPARATOR
Intervention: SAVR
Number of subjects: 750
Study: 24838790

Group type: EXPERIMENTAL
Intervention: Alemtuzumab treatment
Number of subjects: 108
Study: 22750962

Group type: EXPERIMENTAL
Intervention: Dorsal splint
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Volar splint
Number of subjects: 39

Group type: COMPARATOR
Intervention: No splint (control group)
Number of subjects: 39
Study: 19446145

Group type: EXPERIMENTAL
Intervention: Flurbiprofen axetil 50 mg
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control (saline)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Flurbiprofen axetil 50 mg with tourniquet
Number of subjects: 150

Group type: COMPARATOR
Intervention: Tourniquet control (saline)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Mixed flurbiprofen axetil 50 mg and propofol
Number of subjects: 150

Group type: COMPARATOR
Intervention: Mixed control (saline and propofol)
Number of subjects: 150
Study: 17082176

Group type: EXPERIMENTAL
Intervention: NQO1 609*T allele
Number of subjects: 1840

Group type: EXPERIMENTAL
Intervention: Current smokers with heterozygous variant genotype
Number of subjects: 1840

Group type: EXPERIMENTAL
Intervention: Common C/C genotype with alcohol consumption
Number of subjects: 1840

Group type: COMPARATOR
Intervention: mEH3 and mEH4 variants
Number of subjects: 1840
Study: 15746294

Group type: EXPERIMENTAL
Intervention: Power Training (PT)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Strength Training (ST)
Number of subjects: 53
Study: 11802925

Group type: EXPERIMENTAL
Intervention: QuickVue® chlamydia test for high prevalence population
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: QuickVue® chlamydia test for low prevalence population
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: QuickVue® chlamydia test for both populations
Number of subjects: 0

Group type: COMPARATOR
Intervention: Laboratory‐based immunoassay techniques
Number of subjects: 0
Study: 9791638

Group type: EXPERIMENTAL
Intervention: Intervention group (screening)
Number of subjects: 9780

Group type: COMPARATOR
Intervention: Control group (non-screening)
Number of subjects: 9780
Study: 7808885

Group type: EXPERIMENTAL
Intervention: Tinted nonoptical (Irlen) lenses
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 2627821

Group type: EXPERIMENTAL
Intervention: Cimetidine alone
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Cimetidine plus antacid (aluminum hydroxide gel)
Number of subjects: 53
Study: 180938

Group type: EXPERIMENTAL
Intervention: Chemotherapy with carmustine (80 mg/sq m/day for three days) and vincristine sulfate (1.4 mg/sq m on days 1 and 8)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Radiation therapy (4,500 rads whole brain plus 1,500 rads to the side of the tumor)
Number of subjects: 33
Study: 30624012

Group type: EXPERIMENTAL
Intervention: Low-volume tidal peritoneal dialysis (TPD)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Low-volume intermittent peritoneal dialysis (IPD)
Number of subjects: 49
Study: 28246236

Group type: EXPERIMENTAL
Intervention: Alogliptin
Number of subjects: 3808

Group type: COMPARATOR
Intervention: hsTnI ≥99th percentile upper reference limit at 6 months
Number of subjects: 3808

Group type: COMPARATOR
Intervention: Persistently elevated hsTnI
Number of subjects: 3808

Group type: COMPARATOR
Intervention: Undetectable hsTnI at baseline and 6 months
Number of subjects: 3808
Study: 24573974

Group type: EXPERIMENTAL
Intervention: Acellular dermal matrix (ADM)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Subepithelial connective tissue grafts (sCTG)
Number of subjects: 6
Study: 23347535

Group type: EXPERIMENTAL
Intervention: Flaxseed oil (FO) 15 mL/day for 6 weeks
Number of subjects: 37

Group type: COMPARATOR
Intervention: Olive oil (OO) 15 mL/day for 6 weeks
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Flaxseed oil (FO) 15 mL/day
Number of subjects: 37
Study: 21872376

Group type: EXPERIMENTAL
Intervention: Sulodexide 200 mg/d
Number of subjects: 1056

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1056
Study: 19805398

Group type: EXPERIMENTAL
Intervention: Multidimensional prevention programme combining physical training, patient transfer technique and stress management
Number of subjects: 766

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 766

Group type: EXPERIMENTAL
Intervention: Multidimensional prevention programme
Number of subjects: 766
Study: 17409802

Group type: EXPERIMENTAL
Intervention: Docetaxel 75 mg/m2 every 3 weeks
Number of subjects: 111

Group type: COMPARATOR
Intervention: Docetaxel 30 mg/m2 on days 1, 8, and 15 every 28 days
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Docetaxel weekly (30 mg/m2)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Patients with PS 0-1
Number of subjects: 111
Study: 15165646

Group type: EXPERIMENTAL
Intervention: Multidisciplinary palliative care clinic (MD clinic)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Traditional pain and symptom management clinic (PSM clinic)
Number of subjects: 138
Study: 11461753

Group type: EXPERIMENTAL
Intervention: Intravenous magnesium sulfate
Number of subjects: 46

Group type: COMPARATOR
Intervention: Diltiazem
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 46
Study: 9527193

Group type: EXPERIMENTAL
Intervention: High-dose epsilon-aminocaproic acid (10 g loading and priming dose, 2.5 g/h until 4 hours after protamine)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Aprotinin (2 x 10(6) KIU for loading and priming, 0.5 x 10(6) KIU/h)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (10 untreated patients)
Number of subjects: 20
Study: 7993957

Group type: EXPERIMENTAL
Intervention: BRL 46470 (1 mg orally)
Number of subjects: 12

Group type: COMPARATOR
Intervention: mCPP (0.08 mg/kg over 2 min)
Number of subjects: 12
Study: 2597634

Group type: EXPERIMENTAL
Intervention: Clobetasol propionate 0.05% ointment
Number of subjects: 6

Group type: COMPARATOR
Intervention: Base treated sites (control)
Number of subjects: 6
Study: 30099

Group type: EXPERIMENTAL
Intervention: 5 mg diazepam, t.i.d.
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 10 mg chlordiazepoxide, t.i.d.
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Alcohol, 5g/kg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo drink
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo treatment perception
Number of subjects: 40
Study: 31001740

Group type: EXPERIMENTAL
Intervention: Mindfulness
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Qigong
Number of subjects: 52
Study: 30260895

Group type: EXPERIMENTAL
Intervention: Ultrasound
Number of subjects: 223

Group type: COMPARATOR
Intervention: External palpation
Number of subjects: 223
Study: 27142579

Group type: EXPERIMENTAL
Intervention: 2.5% Sodium Hypochlorite (NaOCl)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 2% Chlorhexidine (CHX)
Number of subjects: 50
Study: 24609887

Group type: EXPERIMENTAL
Intervention: IL-1ra (100 mg for 4 weeks)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 22327920

Group type: EXPERIMENTAL
Intervention: Conventional angioplasty
Number of subjects: 48

Group type: COMPARATOR
Intervention: Cryoplasty
Number of subjects: 48
Study: 20164847

Group type: EXPERIMENTAL
Intervention: Amlodipine (10 mg/day) + Olmesartan medoxomil (40 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Amlodipine (10 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Olmesartan medoxomil (40 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 18058482

Group type: EXPERIMENTAL
Intervention: Test formulation of thioctic acid (ALA) 600 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reference formulation of thioctic acid
Number of subjects: 0
Study: 16075942

Group type: EXPERIMENTAL
Intervention: Active treatment (water treatment device with filter and UV light)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sham treatment (no treatment device)
Number of subjects: 50
Study: 12126819

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin
Number of subjects: 999

Group type: EXPERIMENTAL
Intervention: High-intensity oral anticoagulation
Number of subjects: 999

Group type: EXPERIMENTAL
Intervention: Combined low-dose aspirin and moderate intensity oral anticoagulation
Number of subjects: 999
Study: 10567756

Group type: EXPERIMENTAL
Intervention: Painful leading leg's tibialis anterior muscle
Number of subjects: 6
Study: 8712395

Group type: EXPERIMENTAL
Intervention: 10 micrograms/kg intravenous (IV) bolus alfentanil
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 20 micrograms/kg intravenous (IV) bolus alfentanil
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 1789687

Group type: EXPERIMENTAL
Intervention: Octreotide (synthetic analogue of somatostatin) administered intravenously under double-blind, placebo-controlled conditions.
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Octreotide coadministered with physostigmine to 1 patient.
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Octreotide infusion in 6 patients.
Number of subjects: 14
Study: 7044528

Group type: EXPERIMENTAL
Intervention: Tamoxifen-aminoglutethimide-danazol-hydrocortisone (TAD)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Tamoxifen alone
Number of subjects: 107
Study: 31286476

Group type: EXPERIMENTAL
Intervention: Spinal sufentanil (5 µg)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Epidural sufentanil (20 µg)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Spinal fentanyl (20 µg)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Epidural fentanyl (100 µg)
Number of subjects: 80
Study: 28341522

Group type: EXPERIMENTAL
Intervention: Placebo intervention with specific memories and lesser negative expectations regarding itch
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nocebo responders
Number of subjects: 0
Study: 26631330

Group type: EXPERIMENTAL
Intervention: Bacterial cellulose graft (BC)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Autologous temporal fascia (fascia)
Number of subjects: 40
Study: 25345446

Group type: EXPERIMENTAL
Intervention: Moderately intense physical activity (PA) intervention increased from 60 minutes/week to 40 minutes/school day for 3 years
Number of subjects: 223

Group type: COMPARATOR
Intervention: Control group continued with 60 minutes/week of physical activity for 3 years
Number of subjects: 223
Study: 22843280

Group type: EXPERIMENTAL
Intervention: Perampanel 8 mg
Number of subjects: 388

Group type: EXPERIMENTAL
Intervention: Perampanel 12 mg
Number of subjects: 388

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 388
Study: 20598302

Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation (RFA)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Sham (untreated control)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Both RFA and sham
Number of subjects: 113
Study: 18047876

Group type: EXPERIMENTAL
Intervention: Balance Outcome Measure for Elder Rehabilitation (BOOMER)
Number of subjects: 1769

Group type: COMPARATOR
Intervention: Comparison to Modified Elderly Mobility Scale (MEMS)
Number of subjects: 1769

Group type: COMPARATOR
Intervention: Comparison to FIM motor score
Number of subjects: 1769
Study: 15951574

Group type: EXPERIMENTAL
Intervention: Dietary advice, blood glucose monitoring, and insulin therapy as needed
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 1000
Study: 11896093

Group type: EXPERIMENTAL
Intervention: Hormone therapy with megestrol acetate
Number of subjects: 719

Group type: EXPERIMENTAL
Intervention: Hormone therapy with an aromatase inhibitor (fadrozole or letrozole)
Number of subjects: 719

Group type: EXPERIMENTAL
Intervention: Hormone therapy (combined response to both interventions)
Number of subjects: 719
Study: 9707853

Group type: EXPERIMENTAL
Intervention: Dexamethasone 0.5 mg/kg/dose 12 hourly for 3 days starting within 6 hours of birth
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (no drug)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Dexamethasone group
Number of subjects: 19
Study: 8703654

Group type: EXPERIMENTAL
Intervention: meloxicam
Number of subjects: 12
Study: 1973094

Group type: EXPERIMENTAL
Intervention: Combination low sodium, low fat, high fibre diet
Number of subjects: 184

Group type: COMPARATOR
Intervention: Low fat diet
Number of subjects: 184

Group type: COMPARATOR
Intervention: High fibre diet
Number of subjects: 184

Group type: COMPARATOR
Intervention: Low sodium diet
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Combination diet
Number of subjects: 184
Study: 7241356

Group type: EXPERIMENTAL
Intervention: Tablet (50 mg propiram fumarate)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Solution (50 mg propiram fumarate)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Tablet and Solution (comparison)
Number of subjects: 10
Study: 31469982

Group type: EXPERIMENTAL
Intervention: Botulinum toxin injections
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (physiological serum)
Number of subjects: 40
Study: 30569304

Group type: EXPERIMENTAL
Intervention: Food supplementation (1500 kcal/d) from 10 weeks of pregnancy through to the end
Number of subjects: 1360

Group type: COMPARATOR
Intervention: Control (no food supplementation)
Number of subjects: 1360

Group type: EXPERIMENTAL
Intervention: Food supplementation (1500 kcal/d)
Number of subjects: 1360
Study: 27686059

Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Selenium ACE (antioxidants)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 160
Study: 26402350

Group type: COMPARATOR
Intervention: Brief motivational interventions (BMIs)
Number of subjects: 969

Group type: COMPARATOR
Intervention: Single-component BMI focused on correction of misperceptions of descriptive norms
Number of subjects: 969

Group type: COMPARATOR
Intervention: Single-component BMI focused on the use of protective behavioral strategies
Number of subjects: 969
Study: 23852229

Group type: EXPERIMENTAL
Intervention: 0.5% tea
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 2% neem
Number of subjects: 30

Group type: COMPARATOR
Intervention: 0.2% chlorhexidine
Number of subjects: 30
Study: 21498125

Group type: EXPERIMENTAL
Intervention: Dalteparin sodium 2500 IU s.c. daily, in addition to routine luteal phase support
Number of subjects: 172
Study: 19817197

Group type: COMPARATOR
Intervention: Pre-exercise manipulation
Number of subjects: 30

Group type: COMPARATOR
Intervention: Post-exercise manipulation
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Control group (no intervention)
Number of subjects: 30
Study: 20306874

Group type: EXPERIMENTAL
Intervention: In-class content delivery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: At-home study packets
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Online modules
Number of subjects: 0
Study: 15733878

Group type: EXPERIMENTAL
Intervention: Foley catheter
Number of subjects: 140

Group type: COMPARATOR
Intervention: Hyaluronidase
Number of subjects: 140
Study: 12409165

Group type: EXPERIMENTAL
Intervention: Baseline depressive symptoms
Number of subjects: 80

Group type: COMPARATOR
Intervention: Baseline PANSS depression factor scores
Number of subjects: 80
Study: 10220004

Group type: EXPERIMENTAL
Intervention: Early sleep deprivation (ESD)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Late sleep deprivation (LSD)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Recovery sleep after ESD (ESD-R)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Recovery sleep after LSD (LSD-R)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Baseline sleep EEG measures
Number of subjects: 41
Study: 7596934

Group type: EXPERIMENTAL
Intervention: Captopril (12.5 mg bid)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Enalapril (2.5 mg bid)
Number of subjects: 80
Study: 2212184

Group type: EXPERIMENTAL
Intervention: hero/heroine intervention
Number of subjects: 90

Group type: COMPARATOR
Intervention: control group
Number of subjects: 90
Study: 619842

Group type: EXPERIMENTAL
Intervention: Therapy plus drugs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Drugs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Five different treatment methods
Number of subjects: 0
Study: 12100441

Group type: EXPERIMENTAL
Intervention: CQ + SP administered sequentially (CQ0 + SP4)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: CQ + SP administered simultaneously (CQ0 + SP0)
Number of subjects: 32

Group type: COMPARATOR
Intervention: CQ + SP0
Number of subjects: 32

Group type: COMPARATOR
Intervention: CQ + SP4
Number of subjects: 32
Study: 30001723

Group type: EXPERIMENTAL
Intervention: Reminder and recall intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Audit and feedback with education intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined intervention (reminder and recall + audit and feedback with education)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Current course of care (control)
Number of subjects: 0
Study: 26947795

Group type: EXPERIMENTAL
Intervention: Pedal pulse palpation test
Number of subjects: 18681

Group type: EXPERIMENTAL
Intervention: Four palpable pulses
Number of subjects: 18681
Study: 24920915

Group type: EXPERIMENTAL
Intervention: Vildagliptin (50 mg twice daily)
Number of subjects: 557

Group type: COMPARATOR
Intervention: Gliclazide plus metformin
Number of subjects: 557

Group type: EXPERIMENTAL
Intervention: Vildagliptin
Number of subjects: 557
Study: 23365521

Group type: EXPERIMENTAL
Intervention: Strength Training (ST)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Strength Training with Whole-Body Vibration (ST + V)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control (no training)
Number of subjects: 21
Study: 19662486

Group type: EXPERIMENTAL
Intervention: 585-nm pulsed dye laser (PDL) with a pulse duration of 450 micros
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 585-nm pulsed dye laser (PDL) with a pulse duration of 1.5 ms
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 20
Study: 18619813

Group type: EXPERIMENTAL
Intervention: Olive oil-based lipid emulsion (ClinOleic)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Soybean oil-based lipid emulsion (Intralipid)
Number of subjects: 78
Study: 15687338

Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT) - conjugated estrogens (0.625 mg) plus medroxyprogesterone acetate (2.5 mg)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study: 11902622

Group type: EXPERIMENTAL
Intervention: High suppressors
Number of subjects: 1504

Group type: COMPARATOR
Intervention: Low suppressors
Number of subjects: 1504

Group type: EXPERIMENTAL
Intervention: General participants
Number of subjects: 1504

Group type: EXPERIMENTAL
Intervention: Participants evaluating scenarios of discrimination
Number of subjects: 1504

Group type: EXPERIMENTAL
Intervention: Suppression scales
Number of subjects: 1504
Study: 9915375

Group type: EXPERIMENTAL
Intervention: Right half-field patches (n = 7)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Right monocular patch (n = 7)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (n = 8)
Number of subjects: 22
Study: 7770309

Group type: EXPERIMENTAL
Intervention: Nutramigen
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: ProSobee
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Enfamil with Iron, ProSobee, Nutramigen
Number of subjects: 285

Group type: COMPARATOR
Intervention: All formula groups
Number of subjects: 285
Study: 2110338

Group type: EXPERIMENTAL
Intervention: Atropine 1.5 mg/70 kg, intramuscularly
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Atropine 3.0 mg/70 kg, intramuscularly
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Atropine 6.0 mg/70 kg, intramuscularly
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 543889

Group type: EXPERIMENTAL
Intervention: Ampicillin 3 g + Oxacillin 2 g
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ampicillin 2 g + Oxacillin 1 g
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mezlocillin 3.75 g + Oxacillin 1.25 g
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mezlocillin 2 g + Oxacillin 1 g
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Carbenicillin 7.5 g + Oxacillin 2.5 g
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of penicillins
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oxacillin 2.5 g + Carbenicillin 7.5 g
Number of subjects: 0
Study: 30663401

Group type: EXPERIMENTAL
Intervention: Adaptive interventions for engaging patients in treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Proposed analysis method for repeated binary outcomes
Number of subjects: 0
Study: 30397008

Group type: EXPERIMENTAL
Intervention: Development model
Number of subjects: 1266

Group type: EXPERIMENTAL
Intervention: External validation model
Number of subjects: 1266

Group type: EXPERIMENTAL
Intervention: Baseline model
Number of subjects: 1266

Group type: EXPERIMENTAL
Intervention: Updated model
Number of subjects: 1266
Study: 27571011

Group type: EXPERIMENTAL
Intervention: ICD
Number of subjects: 1116

Group type: COMPARATOR
Intervention: Control
Number of subjects: 1116
Study: 25261145

Group type: EXPERIMENTAL
Intervention: Music (Group M)
Number of subjects: 75

Group type: COMPARATOR
Intervention: White noise (Group B)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Ambient noise (Group O)
Number of subjects: 75